Vernon Hills, IL, United States of America

Jia-Ai Zhang


Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2008-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jia-Ai Zhang

Introduction

Jia-Ai Zhang is an accomplished inventor based in Vernon Hills, Illinois. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of two patents to her name, her work focuses on enhancing the efficacy of cancer treatments.

Latest Patents

Jia-Ai Zhang's latest patents include "Stable Sterile Filterable Liposomal Encapsulated Taxane and Other Antineoplastic Drugs." This invention provides a formulation of one or more antineoplastic drugs encapsulated in liposomes, which includes at least a lipid fraction in addition to the antineoplastic drug. The composition is designed to be stable in an aqueous solution at room temperature. Another notable patent is "SN-38 Lipid Complexes and Their Methods of Use." This invention presents novel compositions and methods for treating diseases caused by cellular proliferation, particularly cancer in mammals. The therapeutic compositions include SN-38 lipid complexes that can efficiently incorporate SN-38 into complexes and solubilize relatively high concentrations of the drug.

Career Highlights

Throughout her career, Jia-Ai Zhang has worked with various companies, including Neopharm, Inc. Her expertise in drug formulation and development has positioned her as a valuable asset in the pharmaceutical industry.

Collaborations

Jia-Ai Zhang has collaborated with notable professionals in her field, including Imran Ahmad and Aquilur Rahman. These collaborations have contributed to her innovative work and advancements in cancer treatment.

Conclusion

Jia-Ai Zhang's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight her role as a leading inventor in her field. Her patents reflect her commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…